Juvenescence closes a USD 100 Million Series B round Juvenescence, a life sciences company focused on treating ageing problems, has successfully raised USD 100 Million in…
Category: The Business Cocktail
Aug 15 
Pharma Week | EU approval for Imbruvica; Pharming licenses orphan drug; Sonnet BioTherapeutics buys Relief Therapeutics
EU recommends the use of Imbruvica for two new indications The Janssen Pharmaceutical has received the approval for its drug Imbruvica (ibrutinib) from the European Commission…
Aug 13 
GNA Biosolutions raises USD 13.5M; AC Immune collaborates with Penn; Jazz Pharmaceuticals acquires Cavion; Ascletis opens a new Shanghai clinical research centre
GNA Biosolutions nets USD 13.5 Million in a Series C Funding GNA Biosolutions has secured USD 13.5 Million completing its all the rounds of financing. GNA…
Aug 8 
Pharma Week | NMPA approves ALS treatment Edavarone; GSK ends development of Ebola vaccines; Vesselon Acquires FDA-Approved Imagent
Vesselon Acquires FDA-Approved lipid microsphere drug Imagent Vesselon, an oncology therapeutics company, today acquired an FDA-approved drug Imagent for diagnostic purposes as a contrast agent for…
Aug 6 
Pharma Week| Turalio gets FDA approval; Sosei Heptares, Takeda forms an R&D pact; Acquisition of Breathe Technologies; Exo Imaging emerges from Stealth mode
FDA approves first Tenosynovial giant cell tumour treatment Turalio (Pexidartinib) The US FDA has given its approval to Turalio (pexidartinib) capsules for the treatment of symptomatic…
Aug 1 
Pharma Week | FDA approval for Nubeqa; Biodesix, Immodulon collaborates on Cancer treatment; Cancer asset rights to Alligator Bioscience
Bayer and Orion’s Nubeqa gets FDA recommendations for Prostate Cancer The U.S. FDA has given its nod to Nubeqa (darolutamide) for the treatment of patients with…
Jul 30 
Pharma Week | CHPM’s positive approval for 13 Medicines; NICE approval for AstraZeneca’s Olaparib; Exact Sciences to buy Genomic Health
CHMP opines positively for 13 Drugs for a variety of disease The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA)…
Jul 25 
Pharma Week | Baqsimi wins FDA nod for Hypoglycemia; Freenome captures USD 160M; FDA approval for Ruxience for leukaemia
FDA Approves Eli Lilly’s Baqsimi, the first treatment for Severe Hypoglycemia The U.S. FDA gave its approval to Baqsimi nasal powder, for the treatment of Severe…
Jul 23 
Pharma week | FDA approval for generics Lyrica; CRH Medical Corp. majority purchase of Crystal River Anesthesia; FDA thumbs up for Myxredlin; Salarius conclusion of the merger with Flex Pharma
Generic Lyrica: FDA nods to first generic alternatives to Pfizer’s Lyrica The U.S. FDA has approved the first generic substitute of Pfizer’s Lyrica (pregabalin) in its…
Jul 18 
Pharma Market | PureHealth acquires LYT-100; Sosei raises USD 2.5 M; Orum nets USD 30 M in financing
PureHealth acquires LYT-100 to treat lymphedema PureTech Health, a pioneer in the development of therapies for dysfunctions in the brain-immune-gut axis, has announced to acquire a…
